Isthmus Partners LLC Has $3.98 Million Stake in Plexus Corp. (NASDAQ:PLXS)

Isthmus Partners LLC reduced its stake in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) by 18.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 29,095 shares of the technology company's stock after selling 6,464 shares during the quarter. Isthmus Partners LLC owned 0.11% of Plexus worth $3,978,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of PLXS. Quest Partners LLC grew its stake in shares of Plexus by 36,700.0% during the second quarter. Quest Partners LLC now owns 368 shares of the technology company's stock valued at $38,000 after acquiring an additional 367 shares in the last quarter. Innealta Capital LLC purchased a new position in Plexus in the second quarter valued at about $51,000. Farther Finance Advisors LLC grew its stake in Plexus by 89.4% during the 3rd quarter. Farther Finance Advisors LLC now owns 464 shares of the technology company's stock valued at $63,000 after purchasing an additional 219 shares in the last quarter. Advisors Asset Management Inc. increased its holdings in Plexus by 85.0% during the 3rd quarter. Advisors Asset Management Inc. now owns 664 shares of the technology company's stock worth $91,000 after purchasing an additional 305 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in shares of Plexus by 190.1% in the 3rd quarter. GAMMA Investing LLC now owns 760 shares of the technology company's stock valued at $104,000 after purchasing an additional 498 shares in the last quarter. 94.45% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have recently commented on PLXS shares. KeyCorp started coverage on shares of Plexus in a research report on Tuesday, October 22nd. They set a "sector weight" rating on the stock. StockNews.com raised Plexus from a "hold" rating to a "buy" rating in a report on Monday, November 18th. Needham & Company LLC boosted their price target on Plexus from $144.00 to $162.00 and gave the company a "buy" rating in a report on Friday, October 25th. Finally, Benchmark raised their price objective on Plexus from $150.00 to $165.00 and gave the stock a "buy" rating in a research note on Monday, October 28th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Plexus currently has an average rating of "Moderate Buy" and an average target price of $133.50.

Plexus Stock Performance

Shares of PLXS traded up $2.07 during trading hours on Friday, reaching $164.40. 127,567 shares of the company's stock traded hands, compared to its average volume of 135,295. Plexus Corp. has a twelve month low of $90.18 and a twelve month high of $169.41. The business's fifty day simple moving average is $145.72 and its two-hundred day simple moving average is $125.60. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.51 and a quick ratio of 0.71. The firm has a market capitalization of $4.45 billion, a price-to-earnings ratio of 40.48 and a beta of 0.87.

Plexus (NASDAQ:PLXS - Get Free Report) last posted its quarterly earnings data on Wednesday, October 23rd. The technology company reported $1.85 EPS for the quarter, beating analysts' consensus estimates of $1.55 by $0.30. Plexus had a net margin of 2.82% and a return on equity of 9.51%. The business had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.01 billion. During the same quarter last year, the business earned $1.44 earnings per share. The business's revenue for the quarter was up 2.6% on a year-over-year basis. Analysts predict that Plexus Corp. will post 6.14 earnings per share for the current year.

Insider Buying and Selling

In other news, CFO Patrick John Jermain sold 2,643 shares of the business's stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $166.32, for a total transaction of $439,583.76. Following the sale, the chief financial officer now owns 21,959 shares in the company, valued at $3,652,220.88. The trade was a 10.74 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Michael J. Running sold 539 shares of the firm's stock in a transaction that occurred on Wednesday, November 20th. The stock was sold at an average price of $155.87, for a total transaction of $84,013.93. Following the completion of the transaction, the insider now directly owns 1,030 shares of the company's stock, valued at $160,546.10. This represents a 34.35 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 32,591 shares of company stock worth $5,143,375 in the last ninety days. 2.39% of the stock is currently owned by corporate insiders.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.